We are live on ! Find out more
BCM

Bratton Capital Management Portfolio holdings

AUM $40.7M
1-Year Est. Return 43.1%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+43.1%
3 Year Est. Return
+264.04%
5 Year Est. Return
-20.19%
10 Year Est. Return
AUM
$71.9M
AUM Growth
+$5.16M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AQST icon
1
Aquestive Therapeutics
AQST
$452M
$55.8M 77.67%
11,503,294
DNLI icon
2
Denali Therapeutics
DNLI
$3.79B
$16.1M 22.33%
448,035

Similar funds

Bratton Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Bratton Capital Management held 2 positions worth $71.9M, up 7.7% from $66.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2020: portfolio turnover was 0%. Bratton Capital Management opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Bratton Capital Management's ten largest holdings make up 100% of its $71.9M portfolio in Q3 2020.
  • Bratton Capital Management opened 0 new positions and closed 0 in Q3 2020.
  • Bratton Capital Management's portfolio value rose 7.7% quarter-over-quarter to $71.9M.

Based on Bratton Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.